Welcome to our dedicated page for Anterix SEC filings (Ticker: ATEX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Anterix Inc. filings document the company’s 900 MHz private wireless broadband spectrum business, including material-event reports on spectrum license sale agreements, operating and financial results, Regulation FD updates, and capital-structure disclosures. The records include disclosures tied to broadband license sales, narrowband-to-broadband license exchanges, spectrum clearing costs, contracted proceeds, and the Demonstrated Intent key performance indicator.
The company’s SEC filings also cover governance matters, executive compensation and severance arrangements, shareholder voting matters, risk factors, and regulatory developments affecting broadband use of the 900 MHz band. Material agreements involving its wholly owned subsidiary, PDV Spectrum Holding Company, LLC, are documented through Form 8-K exhibits and related event disclosures.
Anterix Inc. (ATEX) President and CEO Scott A. Lang sold 15,000 shares of common stock on September 21, 2026, at $80 per share. The sale was made under a Rule 10b5-1(c) trading plan adopted June 22, 2026. After the transaction, Lang directly held 26,470 shares.
Anterix Inc. (ATEX) reported that President and CEO, and director, Scott A. Lang sold 15,000 shares of common stock on September 21, 2026 in a sale characterized as an open market or private transaction at $80.00 per share. Following this transaction, he directly holds 26,470 shares of Anterix common stock, and no Rule 10b5-1 trading plan is reported in connection with this sale.
Anterix Inc. (ATEX) received a notice that Scott Lang plans to sell up to 15,000 shares of Anterix common stock under Rule 144 through Morgan Stanley Smith Barney LLC. These shares relate to an option exercise dated June 15, 2026, with the issuer listed as the source of the shares.
The proposed sale has an aggregate value of $1,200,000, based on the market information provided as of September 21, 2026, when 19,609,786 common shares were outstanding. Over the prior three months, Scott Lang sold 35,057 Anterix common shares for total consideration of $3,162,733.86.
Anterix Inc. (ATEX) announced that its Board of Directors authorized a new share repurchase program effective September 22, 2026, following the expiration of its prior program on September 21, 2026. Under this program, the company may repurchase up to $250,000,000 of its common stock on or before September 22, 2029.
The company may buy back shares on the open market and through privately negotiated transactions, potentially using Rule 10b5-1 trading plans. The timing and amount of repurchases will depend on business and market conditions and other strategic factors, and the program can be suspended, discontinued, or modified at any time.
Anterix Inc. (ATEX) reported that officer Martin Heather, Chief Marketing Officer and Chief of Staff, disposed of common stock in two transactions. On September 9, 2026, 3,465 shares were withheld to satisfy tax obligations upon partial vesting of restricted stock units. On September 10, 2026, 8,064 shares were sold in an open-market or private transaction at a weighted average price of $84.2011 per share, with individual sale prices ranging from $84.00 to $84.468. No Rule 10b5-1 trading plan is indicated.
Anterix Inc. (ATEX) reported that Chief Legal Officer & Corp Sec Gena L. Ashe exercised stock options for 6,833 shares of common stock at $34.96 per share on September 8, 2026. The exercise was handled on a cashless basis, with 2,769 shares withheld to cover the exercise price and income tax obligations, and the remaining shares largely sold in open-market transactions.
Anterix Inc. (ATEX) director Leslie B. Daniels reported selling 2,500 shares of common stock on September 10, 2026 in an open-market or private transaction at a weighted average price of $83.83 per share, with individual sale prices ranging from $84.25 to $83.55.
After this sale, Daniels directly held 43,477 shares, and also had indirect holdings of 2,000 shares through an IRA and 5,000 shares through a 401K.
Anterix Inc. (ATEX) has a notice of proposed sale of common stock filed under Rule 144 for the account of Heather Martin. The filing covers the potential sale of 8,064 shares of Anterix common stock, to be handled through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ.
The shares are described as restricted stock acquired from the issuer, and the filing lists an aggregate market value of $678,997.67 for the shares proposed to be sold. The notice is dated September 10, 2026.
Anterix Inc. (ATEX) received a notice under Rule 144 from officer Gena L. Ashe for a proposed sale of up to 4,357 shares of common stock through Morgan Stanley Smith Barney LLC. The shares consist of 293 restricted stock shares and 4,064 shares issuable upon stock option exercise. During the prior three months, Ashe sold 17,711 shares of Anterix common stock.
Anterix Inc. (ATEX) reported that Chief Legal Officer and Corporate Secretary Gena L. Ashe sold an aggregate of 4,357 shares of Anterix common stock on September 8, 2026, in two open-market or private transactions at $85.44 per share. No Rule 10b5-1 trading plan is reported for these sales.